Xu Meng
7Patents
3h-index
8Co-inventors
42Inventor score
Filing activity: Mar 10, 2011 → Dec 13, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8524276B2 | Oral formulations and lipophilic salts of methylnaltrexone | Chemistry; Metallurgy | 9 | Active |
| US9314461B2 | Oral formulations and lipophilic salts of methylnaltrexone | Chemistry; Metallurgy | 7 | Active |
| US8956651B2 | Oral formulations and lipophilic salts of methylnal trexone | Chemistry; Metallurgy | 7 | Active |
| US10307417B2 | Oral formulations and lipophilic salts of methylnaltrexone | Chemistry; Metallurgy | 2 | Active |
| US10507206B2 | Oral formulations and lipophilic salts of methylnaltrexone | Chemistry; Metallurgy | 1 | Active |
| US10376505B2 | Oral formulations and lipophilic salts of methylnaltrexone | Chemistry; Metallurgy | 1 | Active |
| US12036413B2 | Nerve stimulation system | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.